Centurium Capital

Centurium operates a multi-strategy private equity platform. It invests across venture capital (including seed and start-up), growth equity, pre-IPO rounds, buyouts, PIPEs, and even fund-of-funds. The firm also undertakes privatization and restructuring transactions, giving it a uniquely broad mandate for a single China-based manager.

Centurium combines both approaches. While many peers specialize in one stage, Centurium's strategy ranges from early-stage venture deals to control-oriented buyouts. This structure is designed to provide continuous capital support to companies as they scale, rather than forcing founders to switch capital partners at each growth phase.

The firm is headquartered in Beijing and invests primarily in mainland China. Its operations are concentrated on Chinese private companies across the technology, consumer, and healthcare sectors. There is no public indication of significant deal activity outside China.

No. Centurium does not publish an AUM figure or report it to any public database. The firm maintains operational privacy regarding its fund sizes and capital base. Any AUM number would be an estimate and is not confirmed by the firm.

The firm's leadership, including its founding team and current investment committee, is not publicly identified on its website or in available primary sources. Centurium keeps a low public profile, with no named principals verifiable from its own disclosures as of mid-2026.